ScholarLens Back to search
2021•Canadian Medical Association JournalOpen access

Angiotensin-converting-enzyme inhibitor–induced angioedema

Danica Quickfall, Baruch D. Jakubovic, Jonathan S. Zipursky

Open full text 10 citations

Abstract

Angiotensin-converting-enzyme (ACE) inhibitors are responsible for 20%–40% of emergency department visits for angioedema.[1][1] The incidence of ACE inhibitor–induced angioedema is about 0.1%–0.7% in the first 5 years of treatment; symptoms occur within the first month in 10% of cases.[1][1]

Open-access reader

About this research paper

What this paper is about

Angiotensin-converting-enzyme (ACE) inhibitors are responsible for 20%–40% of emergency department visits for angioedema.[1][1] The incidence of ACE inhibitor–induced angioedema is about 0.1%–0.7% in the first 5 years of treatment; symptoms occur within the first month in 10% of cases.[1][1]

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Angiotensin-converting-enzyme (ACE) inhibitors are responsible for 20%–40% of emergency department visits for angioedema.[1][1] The incidence of ACE inhibitor–induced angioedema is about 0.1%–0.7% in the first 5 years of treatment; symptoms occur within the first month in 10% of cases.[1][1]

Key concepts: Angioedema, Angiotensin-converting enzyme, ACE inhibitor, Medicine, Incidence (geometry), Emergency department, Enzyme inhibitor, Enzyme

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Angiotensin-converting-enzyme inhibitor–induced angioedema — Research Paper | ScholarLens